Endocrinology, Vol 127, 1779-1785, Copyright © 1990 by Endocrine Society

ARTICLES

Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami

BL Spangelo, AM Judd, RM MacLeod, DW Goodman and PC Isakson
Department of Medicine, University of Virginia Health Sciences Center, Charlottesville 22908.

Interleukin-6 (IL-6) is an inflammatory cytokine that stimulates T-cell activation and B-cell differentiation. We recently reported that picomolar concentrations of IL-6 stimulated PRL, GH, and LH release in vitro. These data suggested that IL-6 may function as a hypothalamic releasing factor for anterior pituitary hormones. Medial basal hypothalami (MBH) were incubated for 60-90 min in Krebs-Ringer bicarbonate buffer supplemented with 0.025% BSA, and the conditioned medium was assayed for IL-6 concentrations by the 7TD1 cell growth factor assay. It was found that MBH released IL-6 in vitro. Although depolarizing concentrations of K+ (56 mM) did not increase IL-6 release, somatostatin release from the MBH was increased significantly. The bacterial endotoxin lipopolysaccharide (LPS; 1-100 ng/ml) induced significant increases in IL-6 release from the MBH. The presence of IL- 6 in the hypothalamus suggested a possible role for this cytokine in the regulation of neuropeptide release; however, the release of somatostatin was not affected by 20 ng/ml IL-6. Comparison studies of neural and neuroendocrine tissues revealed that the anterior and posterior pituitaries released larger amounts of bioactive IL-6 than the MBH or parietal cortex during a 4-h incubation; induction of IL-6 release by endotoxin occurred only in the anterior pituitary and hypothalamus. IL-6 mRNA was detectable in the MBH and anterior pituitary tissue after a 4-h incubation; however, no IL-6 mRNA was detectable in freshly isolated tissues. LPS (100 ng/ml) and (Bu)2cAMP (1 mM) increased IL-6 mRNA accumulation in and IL-6 release from the MBH and anterior pituitary. These data suggest that the MBH synthesizes and releases IL-6 via a nonneuronal source in vitro.

This article has been cited by other articles:

				F. Barbieri, A. Bajetto, C. Porcile, A. Pattarozzi, G. Schettini, and T. Florio Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function J. Mol. Endocrinol., March 1, 2007; 38(3): 383 - 389. [Abstract] [Full Text] [PDF]

				A. Beishuizen and L. G. Thijs Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis Innate Immunity, February 1, 2003; 9(1): 3 - 24. [Abstract] [PDF]

				C. P. Castro, A. C. Nagashima, M. P. Pereda, V. Goldberg, A. Chervin, P. Largen, U. Renner, G. K. Stalla, and E. Arzt The gp130 Cytokines Interleukin-11 and Ciliary Neurotropic Factor Regulate through Specific Receptors the Function and Growth of Lactosomatotropic and Folliculostellate Pituitary Cell Lines Endocrinology, May 1, 2000; 141(5): 1746 - 1753. [Abstract] [Full Text] [PDF]

				M. J. P. Lenczowski, R.-M. Bluthe, J. Roth, G. S. Rees, D. A. Rushforth, A.-M. van Dam, F. J. H. Tilders, R. Dantzer, N. J. Rothwell, and G. N. Luheshi Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R652 - R658. [Abstract] [Full Text] [PDF]

				J. W. Zumwalt, B. J. Thunstrom, and B. L. Spangelo Interleukin-1{beta} and Catecholamines Synergistically Stimulate Interleukin-6 Release from Rat C6 Glioma Cells in Vitro: a Potential Role for Lysophosphatidylcholine Endocrinology, February 1, 1999; 140(2): 888 - 896. [Abstract] [Full Text]

				J. Raber, R. D. O'Shea, F. E. Bloom, and I. L. Campbell Modulation of Hypothalamic-Pituitary-Adrenal Function by Transgenic Expression of Interleukin-6 in the CNS of Mice J. Neurosci., December 15, 1997; 17(24): 9473 - 9480. [Abstract] [Full Text] [PDF]

				D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text]